Uncategorized
Featured Stories
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
DaVita Inc. to Participate in TD Cowen’s 46th Annual Health Care Conference
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Inc. to Participate in the BofA Securities Healthcare Conference 2023
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the BofA Securities Healthcare Conference 2023 on…
-
DaVita Inc. Schedules 1st Quarter 2023 Investor Conference Call
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 8, 2023, at 5:00 p.m. Eastern Time. The company plans to…
-
Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure
Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) today announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered…
-
DaVita Inc. to Participate in the Barclays 2023 Global Healthcare Conference
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Barclays 2023 Global Healthcare Conference on…
-
DaVita Inc. 4th Quarter 2022 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2022. “We continue to have excitement and conviction in our long-term capabilities and…